Cross-protective immunity induced by omicron variant of SARS-CoV-2
-
Published:2023-12
Issue:
Volume:4
Page:41-44
-
ISSN:2772-6134
-
Container-title:Clinical Immunology Communications
-
language:en
-
Short-container-title:Clinical Immunology Communications
Author:
Chowdhury SeliaORCID, Chowdhury Md. Shahraj, Chowdhury Nurjahan Shipa, Chowdhury Samia, Chowdhury Shajeda
Reference18 articles.
1. Omicron Variant (B.1.1.529) of SARS-CoV-2, A Worldwide Public Health Emergency! 2. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021 3. Meng B., Ferreira I., Abdullahi A., Kemp S.A., Goonawardane N., Papa G., Fatihi S., Charles O., Collier D., Choi J., Lee J.H., Biorxiv. 2021 Jan 1, doi:10.1038/s41586-022-04474-x. 4. Sato K., Suzuki R., Yamasoba D., Kimura I., Wang L., Kishimoto M., Ito J., Morioka Y., Nao N., Nasser H., Uriu K. , 2023 doi:10.1038/s41586-022-04462-1. 5. Plasma Neutralization of the SARS-CoV-2 Omicron Variant
|
|